Reports for XARELTO
Brand name
XARELTO
Company Name
BAYER INC
|
Drug Identification Number
02510162 |
Ingredients
RIVAROXABAN |
Ingredient Strength
51.7 MG |
ATC Code
B01AF |
ATC Descriptor
ANTITHROMBOTIC AGENTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| XARELTO | 100 ML | Resolved | 2021-08-17 | 2021-11-30 | 144273 |
| XARELTO | 100ML | Avoided shortage | 2022-01-28 | 2022-02-09 | 153808 |
| XARELTO | 100mL | Resolved | 2022-07-21 | 2022-08-08 | 165181 |
| XARELTO | 100 mL | Resolved | 2022-10-27 | 2022-11-23 | 172777 |
| XARELTO | 100 ML | Resolved | 2023-03-29 | 2023-06-05 | 188217 |
| XARELTO | 100 mL bottle | Avoided shortage | 2023-06-29 | 2023-11-17 | 196859 |
| XARELTO | 100 mL | Resolved | 2024-01-11 | 2024-02-06 | 215608 |
| XARELTO | 100 mL | Actual shortage | 2025-02-03 | 2025-02-06 | 249440 |
Showing 1 to 8 of 8
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0